Table 1.
Authors (year) | Study design | Country | Study period | Population | Infection associated costs | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Ahsan et al. (2014)16 | A retrospective audit of all cardiac device infections in a single tertiary referral institution | UK | 2004–2007 |
2779 CIEDs implants or CIED-related procedures: 30 infections requiring CIEDs removal |
Average cost: £30 958.40 per incident infection | Cost of cardiac device infection: |
|
|||||
Brough et al. (2018)17 | Retrospective, patient level service line analysis of a single UK extraction centre, during a complete financial year | UK | 2013–2014 | 74 patients required transvenous extraction (47 infected and 27 non-infected; 156 leads)
|
Mean cost of extraction: £9228 (±4099): |
|
When considering additional costs of device reimplantation: |
|
||||
Clémenty et al. (2018)18 | Retrospective analysis using medico-administrative hospital discharge database | France | 2012–2015 | 78 267 CIED patients (72% de novo implants) | 65 553 (84%) PM implantation |
|
11 845 (15%) Defibrillators |
|
2 years infection de novo mean cost per patient |
|
2 years infection replacement mean cost per patient |
|
Egea et al. (2018)19 | Cost analysis based on Delphi panel results on health resource utilization associated with the management of chronic pacemaker complications at the hospital level | Spain | 2017 | NR | Mean cost per infection requiring extraction and considering a 100% reimplantation rate: |
|
Cost for inpatient length of stay: |
|
Mean cost of intravenous antibiotic treatment previous and after system: €833.23/patient | |||
Ludwig et al. (2018)20 | Case-controlled analysis using PSM in patients with ICD/CRT-D using German health insurance claims data | Germany | 2010–2014 |
158/4699 (3.4%) infections Risk of cardiac device infections 12 months post-implant: 3.4% overall, 2.9% for de novo procedures vs. 4.4% for replacement procedures |
Mean 3-year incremental expenditure per patient for patients with cardiac devices infections: |
|
Mean incremental expenditure: €59 419 per patient with a major infection | |||||
Ahmed et al. (2019)21 | Retrospective analysis of clinical case records of pts undergoing extraction for CIED infection at a single tertiary cardiothoracic centre | UK | 2013–2015 | 84 CIED patients
|
|
|||||||
Burnhope et al. (2019)22 | Retrospective cohort of HFrEF patients undergoing ICD or CRT procedures | UK | 2014–2017 | 5/157 patients with CIED infection | Average cost of a CIED infection inpatient admission: £41 820 (range £28 377–£56 498) |
CIED, cardiac implantable electronic device; CRT-D, cardiac resynchronization therapy-defibrillator; CRT-P, cardiac resynchronization therapy-pacemaker; DCP, dual-chamber pacemaker; ICD, implantable cardioverter-defibrillator; HFrEF, heart failure with reduced ejection fraction; PM, pacemaker; PMS, propensity score matching; SCP, single-chamber pacemaker.